Calithera Biosciences (NASDAQ:CALA) stock plunged -6.27% and closed at 3.74. The stock opened the session at $3.96 and touched its highest price point at $3.97. Its recent trading capacity is 985175 shares versus to its average trading volume of 390412 shares. The company’s stock’s lowest price point for the session stood at $3.64.CALA traded as low as $ 3.55 in the past 52 weeks, and shares hit its peak level to $6.9.
Calithera Biosciences (NASDAQ:CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, declared the closing of its previously announced public offering of 14,375,000 shares of common stock, including 1,875,000 shares sold pursuant to the underwriters’ exercise in full of their option to purchase additional shares. Gross proceeds from the offering at a public offering price of $4.00 per share, before underwriting discounts and commissions and offering expenses, were $57.5 million.
SVB Leerink, Wells Fargo Securities and William Blair acted as joint book-running managers for the offering.
A shelf registration statement relating to the offered shares of common stock was filed with the Securities and Exchange Commission (SEC), and was declared effective. A final prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC’s website, located at www.sec.gov. Copies of the prospectus related to the offering may be obtained from SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, Massachusetts 02110, by telephone at 800-808-7525, ext. 6132 or by email at [email protected]; Wells Fargo Securities, LLC, Attention: Equity Syndicate Department, 375 Park Avenue, New York, New York 10152 at 800-326-5897 or email a request to [email protected]; or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or by telephone at 800-621-0687 or email at [email protected]
Calithera Biosciences (CALA) stock observed trading -45.80% off 52-week high price. On the other end, the stock has been noted 5.35% away from low price over the last 52-weeks. The stock disclosed a move of -35.09% away from 50 day moving average and -29.46% away from 200 day moving average. Moving closer, we can see that shares have been trading -28.91% off 20-day moving average. It has market cap of $152.41M .
David Culbreth – Category – Business
David Culbreth is a self-taught investor that has been investing in equities since she was a senior in college and continues to invest. He is extremely devoted to demystifying investing terminology for new investors.
David Culbreth is a senior author and journalist. He has more than 5 years of experience in institutional investment markets, including fixed income, equities, derivatives and real estate. David has a Bachelor in Business Administration with a major in Finance. He bought his first stocks in a private business at age 15 and made his first public stock trade at 23. He has always been interested in the stock market and how it behaves.
As the dad of two children, he’s made saving money and investing for them a high priority. Over many years of investing, he has made some wise choices and he’s made many mistakes. But he’s learned from both. Mr. David observations and experience give him the insight to stock market patterns and the investor behaviors that create them.
Email Contact – [email protected]
Address – 1964 40th Street, Calgary, Alberta
Zip Code – T2E 6X1
Phone Number – 403-369-2886